This week saw the approval for Sun Pharma’s first biologic program along with a supplemental approval for Seattle Genetics. Here is my recap of the top regulatory news stories for this week: The FDA on Monday officially launched its pilot project to publicly release portions of clinical trial-related summaries from pivotal trials, with initial data[…]